JLL’s 2014 Global Life Sciences Cluster Report identifies the top U.S. cities for biotech business and research
Global shifts in the life sciences landscape may be rewriting the global map, but U.S. cities continue to lead the world in biopharmaceutical resources and enterprises. Access to talent and research is keeping cities, including Boston, San Francisco, San Diego and New Jersey/NYC/Westchester at the top of the U.S. life sciences clusters list. In fact, despite headquarter relocations and consolidations, the 2014 cluster report saw New Jersey/NYC/Westchester gain two positions as compared to the 2013 cluster report, ranking fifth on the list of U.S. cities.
From a real estate perspective, the need to streamline costs, combat the threat of non-compliance issues and fill talent shortages is leading to increased outsourcing in facilities management. Additionally, the trends seen on a global level are stimulating significant changes to space needs: mid-tier companies and specialty players are spurring a majority of new demand while the larger life sciences players are looking for strategic portfolio planning as their businesses transform.
Click here to download the full Global Life Sciences Cluster Report which further explores these trends and outlines key global regions to watch.
Watch the video for highlights of the report: